Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy

被引:0
作者
Claudia Blattmann
Susanne Oertel
Markus Thiemann
Anne Dittmar
Eva Roth
Andreas E. Kulozik
Volker Ehemann
Wilko Weichert
Peter E. Huber
Albrecht Stenzinger
Jürgen Debus
机构
[1] University of Heidelberg,Department of Radiation Oncology
[2] University Children’s,Department of Pediatric Oncology, Hematology and Immunology
[3] Hospital of Heidelberg,Institute of Pathology
[4] University of Heidelberg,Department of Radiation Oncology
[5] German Cancer Research Center,National Center for Tumor Diseases (NCT)
[6] German Cancer Consortium (DKTK),undefined
[7] University of Heidelberg,undefined
[8] Pädiatrie 5,undefined
[9] Olgahospital,undefined
来源
Radiation Oncology | / 10卷
关键词
Osteosarcoma; Carbon ion radiotherapy; Histone deacetylase inhibition; Suberoylanilide hydroxamic acid; Radiosensitization; Mouse model;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 158 条
[21]  
Okada T(2011)Review of clinical experience with ion beam radiotherapy Br J Radiol 84 35-89
[22]  
Matsunobu A(2005)Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Birn Proc Natl Acad Sci U S A 44 16090-8
[23]  
Imai R(2010)HDAC inhibition synergistically enhances alkylator-induced DNA damage responses and apoptosis in multiple myeloma cells Cancer Lett 296 233-604
[24]  
Kamada T(2010)Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of Annexin A1 Cancer Lett 295 85-90
[25]  
Imaizumi T(2009)Enhancing the apoptotic and therapeutic effects of HDAC inhibitors Cancer Lett 280 125-95
[26]  
Tsuji H(2010)Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect Invest New Drugs 28 3-48
[27]  
Tsujii H(2003)Role of caspases, Bid and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA) J Biol Chem 278 12579-84
[28]  
Combs SE(2003)Histone seacetylase inhibitors in cancer therapy: Is transcription the primary target? Cancer Cell 4 13-undefined
[29]  
Kessel KA(2002)Live or let die: the cell’s response to p53 Nat Rev Cancer 2 594-undefined
[30]  
Herfarth K(2006)Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1) Mol Cell Biol 26 2782-undefined